Special Issue "Novel Players in Chemioresistance as New Targets for Cancer Treatment"
Deadline for manuscript submissions: 30 November 2021.
Interests: cancer; chemoresistance; nucleolar stress; extra-ribosomal function of ribosomal proteins; cell cycle
Special Issues and Collections in MDPI journals
Cancer is one of the most common causes of death among adults. In the past decades cancer management was restricted to surgery, radiation therapy and chemotherapy either as single treatments or as combination therapy. However, the development of multidrug resistance continues to pose a significant challenge in cancer therapies. Therefore, a better understanding of the molecular basis underlying the mechanisms of drug resistance is necessary to produce improved guidance to future cancer treatment. This special issue aims at collect new discovery in the mechanisms of drug resistance, focusing on the therapeutic potential of targeting new pathways involved in chemoresistance.
The article may be either a full paper or a communication based on your own research in this area, or may be a focused review article on some aspect of the subject.
Dr. Annapina Russo
Dr. Giulia Russo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- mechanisms of drug resistance
- anticancer therapy
- personalized therapies
- combinatorial anticancer strategies
- novel target drugs
- molecular pathways underlying chemoresistance
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
1. Confined space migration manifests therapy resistance in Glioblastoma multiforme cells /via/ ABC transporter(s) upregulation